CANDY SUAREZ: Open Payments
NPI 1497177406 · HAYMARKET, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 33 payments from 12 companies in 2025. Trend: 2023 $679 · 2024 $463 · 2025 $1,209
Food & beverage: $1,059Education: $150
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 1 | $238 |
| Collegium Pharmaceutical, Inc. | 16 | $191 |
| Fidia Pharma USA Inc. | 2 | $174 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $154 |
| ABBVIE INC. | 1 | $125 |
| MML US, Inc. | 2 | $79 |
| TerSera Therapeutics LLC | 2 | $79 |
| BIOTRONIK NRO, Inc. | 2 | $58 |
| Boston Scientific Corporation | 1 | $56 |
| SCILEX PHARMACEUTICALS INC. | 1 | $23 |
Products named: QUTENZA, RICHPLAT ORTHO PRP SYSTEM, QULIPTA, Belbuca, ReActiv8, Prialt, XTAMPZA, Prospera.
Industry payments across VA — which companies pay providers there.
